- Report
- January 2026
- 181 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- March 2025
- 175 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- October 2025
- 160 Pages
Global
From €3467EUR$3,950USD£3,017GBP
- Report
- August 2025
- 154 Pages
Global
From €2546EUR$2,900USD£2,215GBP
- Report
- July 2025
- 150 Pages
Global
From €5223EUR$5,950USD£4,544GBP
- Report
- January 2026
- 181 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- January 2026
- 199 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- November 2025
- 188 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- August 2025
- 182 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- August 2025
- 186 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- August 2025
- 196 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- August 2025
- 182 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- August 2025
- 199 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- August 2025
- 186 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- February 2026
- 270 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 340 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1097EUR$1,250USD£955GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1097EUR$1,250USD£955GBP
- Report
- January 2026
- 180 Pages
Global
From €3950EUR$4,500USD£3,437GBP
- Report
- January 2026
- 130 Pages
Global
From €4169EUR$4,750USD£3,627GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more